Description: Taj Pharma India is well known Manufacturer, Exporter and Supplier of Epalrestat (EPATAJ) from Vapi, Gujarat India.is an aldose reductase inhibitor. It blocks the accumulation of sorbitol in cells, which has been related to causing diabetic nerve diseaseWe are a reputed manufacturer, exporter, and supplier of Epalrestat Sustained Release Tablets 150mg (EPATAJ) in India, delivering high-quality pharmaceutical solutions for the management of diabetic neuropathy. Epalrestat is an aldose reductase inhibitor that helps control nerve damage caused by diabetes by reducing sorbitol accumulation in nerve tissues. This action helps relieve common neuropathic symptoms such as burning sensation, tingling, numbness, and chronic nerve pain. Our Epalrestat 150mg sustained release formulation is developed with advanced drug delivery technology that ensures gradual and controlled release of the active ingredient. This improves therapeutic effectiveness, enhances patient compliance, and provides long-lasting relief with once-daily dosing. Each batch is manufactured in a WHO-GMP certified facility in Vapi, Gujarat, India, under strict quality assurance protocols to ensure safety, purity, and consistency. We supply Epalrestat Tablets 150mg to global markets including Africa, the Middle East, and Latin America (LATAM), supporting healthcare distributors, wholesalers, and pharma partners with reliable and affordable diabetic care products. Our strong export capabilities ensure timely delivery and uninterrupted supply. In addition, we provide PCD Pharma Franchise opportunities, enabling business partners to expand in the fast-growing diabetic therapeutic segment with strong market demand. With a commitment to quality, innovation, and global healthcare standards, we continue to strengthen our position as a trusted pharmaceutical exporter of Epalrestat Sustained Release Tablets 150mg, improving diabetic neuropathy management worldwide
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 202 KB
